363
Participants
Start Date
August 31, 2011
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Desvenlafaxine Succinate Sustained-Release
Subjects randomized to DVS SR treatment arm will receive 25, 35, or 50 mg/day based on subject weight at the Baseline visit.
Desvenlafaxine Succinate Sustained-Release
Subjects randomized to DVS SR treatment arm will receive 20, 25, or 35 mg/day based on subject weight at the Baseline visit.
Placebo
Subjects randomized to the Placebo treatment arm will receive placebo tablets
Bioscience Research, LLC., Mount Kisco
The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks
Erie County Medical Center / State University of New York at Buffalo affiliate, Buffalo
Finger Lakes Clinical Research, Rochester
Pharmasite Research Inc, Baltimore
Alliance Research Group, Richmond
Virginia Commonwealth University, Richmond
Virginia Treatment Center, Richmond
Carilion Medical Center, Roanoke
Northwest Behavioral Research Center, Marietta
Clinical Neuroscience Solutions, Jacksonville
SJS Clinical Research, Inc., Destin
Sarkis Clinical Trials, Gainesville
Medical Research Group of Central Florida, Orange City
Millenia Psychiatry & Research, Inc., Orlando
Janus Center for Psychiatric Research, West Palm Beach
Children's Hospital of Alabama Laboratory, Birmingham
The University of Alabama at Birmingham, Office of Psychiatric Research, Birmingham
Research Strategies of Memphis, LLC., Memphis
Discovery and Wellness Center for Children/University Hospitals Case Medical Center, Cleveland
Neuro-Behavioral Clinical Research, Inc., Canton
Clinco, Terre Haute
Capstone Clinical Research, Libertyville
AMR-Baber Research Inc., Naperville
Millennium Psychiatric Associates, LLC, Creve Coeur
Premier Psychiatric Research Institute, LLC, Lincoln
Louisiana State University Health Sciences Center-Psychopharmacology Research Clinic, Shreveport
Drug:University Health Shreveport Outpatient, Shreveport
Sooner Clinical Research, Oklahoma City
Clinical Trials of Texas, Inc., San Antonio
FutureSearch Trials, Austin
MCB Clinical Research Centers, Colorado Springs
Center for Advanced Improvement, Tucson
Sun Valley Research Center, Imperial
Eastside Therapeutic Resource, Kirkland
Biomedica Research Group, Santiago
Optima Salud, Santiago
Bliss Basement Pharmacy - Hartford Hospital, Hartford
Institute of Living/Hartford Hospital, Hartford
Institute of Living, Hartford
Stony Brook University Medical Center, Child And Adolescent Psychiatry, Stony Brook
Hospital Universitario Dr. Jose Eleuterio Gonzalez, Departamento de Psiquiatria, Monterrey
Lead Sponsor
Pfizer
INDUSTRY